90579137 - ISARNA THERAPEUTICS

Information

  • Trademark
  • 90579137
  • Serial Number
    90579137
  • Filing Date
    March 15, 2021
    3 years ago
  • Transaction Date
    October 17, 2024
    3 months ago
  • Status Date
    October 16, 2024
    3 months ago
  • Published for Opposition Date
    May 17, 2022
    2 years ago
  • Location Date
    July 12, 2022
    2 years ago
  • Status Code
    734
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    WATSON, JULIE
  • Attorney Docket Number
    752788
    Attorney Name
    Claudia W. Stangle
    Law Office Assigned Location Code
    L90
  • Owners
Mark Drawing Code
4
Mark Identification
ISARNA THERAPEUTICS
Case File Statements
  • GS0051: Pharmaceutical and veterinary preparations for the treatment of tumors, pain, neurological diseases, liver disease, ophthalmologic diseases, pulmonary disease, renal diseases, and any other disease that is associated with the biologic action of Transforming Growth Factor beta (TGF-b) of the human body or of animals; sanitary preparations for medical purposes; liquids, solutions or active agents for use in the pharmaceutical and veterinary field, namely, for the treatment of tumors, pain, neurological diseases, liver disease, ophthalmologic diseases, pulmonary disease, renal diseases, and any other disease that is associated with the biologic action of Transforming Growth Factor beta (TGF-b) of the human body or of animals
  • GS0441: Medical services in the pharmaceutical field, namely, the treatment of tumors, pain, neurological diseases and similar malfunctioning of the human body; veterinary services in the field of the treatment of tumors, pain, neurological diseases and similar malfunctioning of animals; hygienic and beauty care for human beings or animals, using liquids, solutions or active agents in the cosmetic field, namely, the plastic surgery and anaplastic field or anti-aging treatment
  • DS0000: "THERAPEUTICS"
  • GS0421: Scientific and technological services, namely, research and design relating thereto in the pharmaceutical and veterinary field, namely, for the treatment of tumors, pain, neurological diseases and similar malfunctioning of the human body or of animals; industrial analysis in the nature of testing pharmaceuticals to ensure compliance with industry standards; providing scientific research services in the fields of medicine, namely, research on tumor treatment, pain, neurological diseases and similar malfunctioning of the human body or of animals; design and development of computer hardware and software in the pharmaceutical and veterinary field, namely, for the treatment of tumors, pain, neurological diseases and similar malfunctioning of the human body or of animals
Case File Event Statements
  • 10/14/2021 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/18/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 6/14/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 10/14/2021 - 3 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/14/2021 - 3 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/14/2021 - 3 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/11/2022 - 2 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/11/2022 - 2 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/11/2022 - 2 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/11/2022 - 2 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/13/2022 - 2 years ago
    11 - ASSIGNED TO LIE Type: ALIE
  • 4/13/2022 - 2 years ago
    12 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 4/27/2022 - 2 years ago
    13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/17/2022 - 2 years ago
    14 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/17/2022 - 2 years ago
    15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/12/2022 - 2 years ago
    16 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 12/8/2022 - 2 years ago
    17 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/8/2022 - 2 years ago
    18 - SOU EXTENSION 1 FILED Type: EXT1
  • 12/8/2022 - 2 years ago
    19 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 12/10/2022 - 2 years ago
    20 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/14/2023 - a year ago
    21 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 6/14/2023 - a year ago
    22 - SOU EXTENSION 2 FILED Type: EXT2
  • 6/14/2023 - a year ago
    23 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 6/16/2023 - a year ago
    24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/12/2023 - a year ago
    25 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/12/2023 - a year ago
    27 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 12/12/2023 - a year ago
    26 - SOU EXTENSION 3 FILED Type: EXT3
  • 6/17/2024 - 7 months ago
    29 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/16/2024 - 3 months ago
    33 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/16/2024 - 3 months ago
    36 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/16/2024 - 3 months ago
    34 - SOU EXTENSION 5 FILED Type: EXT5
  • 10/16/2024 - 3 months ago
    35 - SOU EXTENSION 5 GRANTED Type: EX5G
  • 12/14/2023 - a year ago
    28 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/17/2024 - 7 months ago
    32 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/17/2024 - 7 months ago
    30 - SOU EXTENSION 4 FILED Type: EXT4
  • 6/17/2024 - 7 months ago
    31 - SOU EXTENSION 4 GRANTED Type: EX4G